Caroline Downey is a staff writer for National Review.
Caroline Downey
Caroline Downey connects today's culture to eternal truth, providing the grounded perspective for every generation.
13:17
This Company Claims to Cure Genetic Illness. There’s a Disturbing Catch.
When groundbreaking biotech firms advertise miraculous cures for rare hereditary conditions, the ethical, financial, and moral tradeoffs behind cutting-edge gene therapies demand rigorous scrutiny. Caroline Downey breaks down the disturbing catch behind a biotechnology company claiming to cure genetic illness, analyzing the controversial practices, prohibitive price tags, and unintended consequences associated with experimental genetic modification. Unpacking the complex intersection of bioethics, corporate profit motives, and human dignity, Caroline examines how selective gene editing, pre-implantation screening, and profit-driven medicine challenge fundamental moral boundaries in modern healthcare. What does this troubling development in genetic engineering reveal about the dark side of corporate bio-innovation and the urgent need for ethical guardrails in medical science? Watch Caroline’s full analysis, leave your thoughts below, and subscribe to National Review!
Comments
On “This Company Claims to Cure Genetic Illness. There’s a Disturbing Catch.”